Table 2 comparison of diabetes genetic risk scores according to diabetes control as defined by HbA₁c levels, by survey period, CoLaus study, Lausanne, Switzerland

Second follow-up (N)

132

92

132

92

Andersson

40.0 ± 4.6

40.7 ± 5.1

0.291

40.0 ± 0.4

40.6 ± 0.5

0.423

Martono

62.1 ± 4.7

61.0 ± 4.5

0.085

62.2 ± 0.4

61.1 ± 0.5

0.105

Szcerbinski

0.53 ± 0.41

0.50 ± 0.37

0.585

0.54 ± 0.04

0.50 ± 0.05

0.524

Werissa

17.5 ± 3.3

17.5 ± 3.1

0.992

17.6 ± 0.3

17.5 ± 0.4

0.759

Liu

2.88 ± 0.34

2.80 ± 0.32

0.100

2.89 ± 0.03

2.80 ± 0.04

0.067

Pechlivanis

109 ± 6

107 ± 6

0.069

109 ± 1

107 ± 1

0.129

Wang

1.49 ± 0.38

1.47 ± 0.38

0.748

1.50 ± 0.03

1.47 ± 0.04

0.542

Large score

126 ± 9

128 ± 11

0.134

126 ± 1

128 ± 1

0.070

Short score

9.8 ± 2.2

9.8 ± 2.4

0.986

9.8 ± 0.2

9.7 ± 0.3

0.840

Third follow-up (N)

95

62

95

62

Andersson

39.2 ± 4.5

41.1 ± 4.8

0.011

39.2 ± 0.5

41.0 ± 0.6

0.023

Martono

61.8 ± 4.8

62.2 ± 5.3

0.579

61.7 ± 0.5

62.3 ± 0.6

0.509

Szcerbinski

0.48 ± 0.43

0.58 ± 0.42

0.154

0.48 ± 0.04

0.58 ± 0.05

0.149

Werissa

17.1 ± 3.6

17.9 ± 3.1

0.189

17.1 ± 0.3

17.9 ± 0.4

0.188

Liu

2.83 ± 0.37

2.86 ± 0.33

0.669

2.83 ± 0.04

2.86 ± 0.05

0.671

Pechlivanis

109 ± 6

109 ± 7

0.880

109 ± 1

109 ± 1

0.582

Wang

1.52 ± 0.42

1.43 ± 0.34

0.175

1.52 ± 0.04

1.43 ± 0.05

0.172

Large score

125 ± 10

127 ± 10

0.250

125 ± 1

127 ± 1

0.351

Short score

9.4 ± 2.2

10.0 ± 2.4

0.114

9.4 ± 0.2

10.0 ± 0.3

0.123